PARS Financials 07/16/2014 14:52:28
Pharmos Corp.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development 871 253
Sales, General and Admin. 1,006 1,187
Non-Recurring Items - -
Other 3 2
Operating Income (1,879) (1,442)
Income From Continuing Operations
Add'l Income/Expense Items 3 7
Earnings Before Interest and Tax (1,876) (1,435)
Interest Expense 103 111
Earnings Before Tax (1,979) (1,546)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (1,979) (1,546)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (1,979) (1,546)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (1,979) (1,546)